Objective Antibody response to the messenger RNA (mRNA) COVID‐19 vaccine has been
shown to be diminished in rituximab (RTX)–treated patients. We undertook this study to …

Background Evidence suggests an important role for gut-microbiota dysbiosis in the
development of rheumatoid arthritis (RA). The link between changes in gut bacteria and the …

Objective: To compare the efficacy of methotrexate (MTX) and mycophenolate mofetil (MMF)
in the prevention of relapses in neurosarcoidosis. Methods: We conducted a retrospective …

Fatty livers occur in up to 20% of potential liver donors and increase cellular injury during the
ischemia/reperfusion phase, so any intervention that could enable a better outcome of grafts …

Patients with multiple myeloma are at high risk of severe forms of COVID-19. Despite data
showing diminished response to vaccine, the era of highly efficient mRNA vaccine might be …

Objectives TNF inhibitors (TNFi) can induce anti-drug antibodies (ADA) in patients with
autoimmune diseases (AID) leading to clinical resistance. We explored a new way of using …

Importance There are conflicting data on the association of antidrug antibodies with
response to biologic disease–modifying antirheumatic drugs (bDMARDs) in rheumatoid …

Background: Rheumatoid arthritis (RA) is the most common autoimmune rheumatic disease
and leads to persistent chronic inflammation. The pathophysiology of the disease is …

Pegylation of biopharmaceuticals is the most common strategy to increase their half-life in
the blood and is associated with a reduced immunogenicity. As antigen presentation is a …

Objective To describe the clinical efficacy of tixagevimab/cilgavimab in pre-exposure
prophylaxis in patients at risk of severe coronavirus disease 2019 (COVID-19) and …